Menu

PHI’s CHDS Produces Special Issue of “Reproductive Toxicology” on Pregnancy Exposure and Breast Cancer

Highlights

Singleton women, part of the CHDS research and featured in news coverage on the links between DDT exposure and breast cancer

By exploring the relationship between exposures in pregnancy to the risk of breast cancer in mothers and their daughters, PHI's Child Health and Development Studies is helping to find a path to preventing breast cancer in future generations.

15 articles & commentaries in the Spring 2020 issue of "Reproductive Toxicology," on the connections to pregnancy exposures and breast cancer risk for mothers and their daughters

PHI’s Child Health and Development Studies (CHDS) researchers and collaborators have produced a special issue of the journal, Reproductive Toxicology, co-edited by Barbara Cohn, CHDS Director, and Mary Beth Terry, Mailman School of Public Health, Columbia University.

This special issue, released in the spring of 2020, is comprised of 13 articles and two distinguished commentaries on the relation of exposures in pregnancy to the risk of breast cancer in mothers and their daughters. These two-generation CHDS studies are unique, cover incident breast cancer in relation to legacy and current environmental chemicals (including PFASs), widespread current contaminants, epigenomic consequences, the role of the placenta, and impact of environmental chemicals on breast density and related experimental toxicology and metabolome-wide association studies.

This special issue includes a commentary titled CHDS: A National Treasure that Keeps on Giving, by Suzanne Fenton, Group Leader, Reproductive Endocrinology, National Institute of Environmental Health Sciences, and Linda Birnbaum, Director Emeritus, National Institute of Environmental Health Sciences, and a forward by Marion Kavanaugh Lynch, Director of the California Breast Cancer Research Program.

This body of research firmly establishes the importance of ancestral environmental exposures in the occurrence of breast cancer and provides a new look at prevention opportunities based on biomarkers of exposure and public policy to protect mothers during pregnancy and thus their daughters before birth.

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Close

PHI's Top 24 Impacts for 2024

During 2024, PHI worked alongside our partners to advance public health research, policies, programs and interventions in communities around the globe. Explore some of our most impactful work in 2024—a collection of our top stories, tools, resources and ideas that helped to improve health, advance equity and build community power.

See the impacts

Continue to PHI.org